Fall Skin Care Sale

Life Extension Update

July 23, 2005 Printer Friendly
In this issue

Life Extension Update Exclusive

Scientists demonstrate inflammation’s effect on glucose levels

Protocol

Chronic inflammation

Featured Products

ArthroMax™

 

Mega GLA with Sesame Lignans

Membership

Join the Life Extension Foundation

Life Extension Update Exclusive

Scientists demonstrate inflammation’s effect on glucose levels

The Therapeutic Approaches to Obesity and Related Disorders conference held in Washington DC was the site of a presentation on July 22 by scientists from Galileo Pharmaceuticals concerning the demonstration of a direct relationship between inflammation and glucose levels. The finding adds to a growing body of information linking inflammation with a number of diseases and age-related conditions.

Using a mouse model of diabetes, Galileo researchers administered a 5-lipoxygenase and 15-lipoxygenase inhibitor and measured the animals’ blood glucose and insulin levels. Lipoxygenases are enzymes that are involved in the production of leukotrienes, which are mediators of inflammation. Five and 15-lipoxygenase have been implicated in asthma, arthritis, atherosclerosis, diabetes, osteoporosis, and cancer. The scientists observed a 20 percent reduction in the animals’ blood glucose levels while insulin levels remained the same--results that are comparable to those of a leading antidiabetic drug

Lloyd M. Kunimoto, who is the president and chief executive officer of Galileo Pharmaceuticals, stated, "Metabolic disease is a health concern of near-epidemic proportions, particularly in the US. We are encouraged by our initial study, which confirms the role of inflammation in the regulation of carbohydrate and lipid metabolism. “

"There is increasing scientific evidence that suggests that inflammation is a key component of onset and progression of metabolic disease,” added Galileo Pharmaceuticals’ chief scientific officer and executive vice president of research and development, David Liebowitz, MD, PhD. “We have already identified potent lipoxygenase inhibitors that have shown activity in preclinical animal models of diabetes and are evaluating more potent and pharmacologically optimized leads in appropriate animal models."

Protocol

Chronic inflammation

Chronic systemic inflammation is an underlying cause of many seemingly unrelated, age-related diseases. As humans grow older, systemic inflammation can inflict devastating degenerative effects throughout the body (Ward 1995; McCarty 1999; Brod 2000). This fact is often overlooked by the medical establishment, yet persuasive scientific evidence exists that correcting a chronic inflammatory disorder will enable many of the infirmities of aging to be prevented or reversed.

In a study published in the July 18, 2001 issue of the Journal of the American Medical Association, a group from the famous Women's Health Study was evaluated to ascertain what risk factors could predict future development of Type II diabetes (Pradhan et al. 2001). The findings showed that baseline levels of C-reactive protein and interleukin-6 (IL-6) were significantly higher among those who subsequently developed diabetes compared to those who did not.

When comparing the highest versus lowest quartile, women with the higher IL-6 levels were 7.5 times more likely to develop diabetes while those in the higher C-reactive protein ranges were 15.7 times more likely to become diabetic. After adjusting for all other known risk factors, women with the highest IL-6 levels were 2.3 times at greater risk, while those with the highest C-reactive protein levels were 4.2 times more likely to become diabetic. It should be noted that these other diabetic risk factors (such as obesity, estrogen replacement therapy and smoking) all sharply increase inflammatory markers in the blood. The doctors who conducted this study concluded by stating:

"Elevated C-reactive protein and IL-6 predict the development of Type II diabetes mellitus. These data support a possible role for inflammation in diabetogenesis."

http://www.lef.org/protocols/prtcl-146.shtml

Featured Products

ArthroMax™

As people grow older, structural alterations occur in their joints that lead to discomfort and loss of mobility. While conventional doctors rely on prescription drugs, scientists have identified a number of natural agents that provide broad-spectrum support for healthy joint function and structure.

Glucosamine provides the underlying structural foundation for joints, while methylsulfonylmethane (MSM) provides crucial sulfur compounds that are so important to maintain comfortable joint function.

Nobiletin is a citrus flavonoid that has demonstrated potent effects in suppressing destructive cytokines such as tumor necrosis factor alpha and interleukin-1 beta. In addition, nobiletin limits the production of joint damaging prostaglandin E2. A special Boswellia extract known as 5-Loxin® inhibits the 5-lipooxygenase enzyme, reducing levels of joint damaging leukotriene B4.

ArthroMax™ combines these potent nutrients into one convenient formula for health joints.

http://www.lef.org/newshop/items/item00682.html

Mega GLA with Sesame Lignans

Omega-6 fatty acids are well supplied in the diet by meat and vegetable oils. However, not all omega-6 fatty acids are of equal value. Gamma linolenic acid (GLA), found in evening primrose oil, borage oil, and black currant oil is an important fatty acid that plays a beneficial role in healthy prostaglandin formation.

Health conscious people have been consuming a lot of borage oil to obtain GLA (gamma-linolenic acid), the parent of the biologically active DGLA (di-homo-gamma-linolenic acid). Life Extension has added 10 milligrams of sesame lignans to each capsule of Mega GLA borage oil. Sesame lignans not only increase beneficial DGLA, but they also help reduce production of pro-inflammatory arachidonic acid, which decreases the formation of destructive prostaglandin E2 and leukotriene B4.

http://www.lef.org/newshop/items/item00756.html

Membership

Join the Life Extension Foundation

Too many people are dying today as a result of medical ignorance and apathy. The Life Extension Foundation is breaking down the bureaucratic barriers that deny human beings access to validated life-saving therapies. If you join the Life Extension Foundation today, you’ll receive:

The 1,665-page reference book called Disease Prevention and Treatment. This hardcover fourth edition reveals what doctors are NOT doing to save the lives of their patients and contains novel approaches to prevent and treat 134 medical disorders.

Life Extension magazine…an over 100-page monthly publication filled with medical research findings, inside scientific reports, and practical guidance about using nutrients and hormones to slow aging.

Discounts on prescription medications, blood tests, and dietary supplements that greatly exceed the membership dues.

All members receive exciting benefits and discounts on products and services offered by select partner companies, such as Hertz and Bally’s. Members can earn additional benefits based on their product purchase history through the Life Extension Buyers Club.

And more!

http://www.lef.org/featured-articles/benefits.html

Questions? Comments? Send them to ddye@lifeextension.com or call 954 202 7716.

For longer life,

Dayna Dye
Editor, Life Extension Update
ddye@lifeextension.com
LifeExtension.com
1100 West Commercial Boulevard
Fort Lauderdale FL 33309
954 766 8433 extension 7716

Sign up for Life Extension Update at http://mycart.lef.org/subscribe.asp

Help spread the good news about living longer and healthier. Forward this email to a friend!

View previous issues of Life Extension Update in the Newsletter Archive.